Skip to main content

Understanding Sexual Dimorphism in Sjögren's

No Ratings


2023 AADOCR/CADR Annual Meeting

The 2023 AADOCR/CADR Annual Meeting & Exhibition provided dental, oral, and craniofacial health scientists with the opportunity to present, discuss, and critique their latest and most cutting-edge research at a 100% in-person gathering in Portland, Oregon. The meeting was attended by 2,054 individuals from 39 countries.     

The recordings in this library from the meeting are a selection of the science that was presented at the Annual Meeting. These recordings give you the opportunity to participate in the meeting and hear from leading researchers. The recordings include IADR Distinguished Lecture Series speakers and symposia from a collection of scientific groups and networks.

This session can be purchased as part of the full meeting recordings within the product bundles





The International Association for Dental Research is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Session Description 
Autoimmune conditions predominantly affect women. Among these, Sjögren's is extremely sexually dimorphic; more than 90% of patients are female. The mechanism for this strong sex bias remained largely unknown for many years. In 2016, an X chromosome dose effect was reported where trisomy X (47,XXX) increased female risk of developing Sjögren's , and men with Klinefelterâ's syndrome (47,XXY) were at a similar risk of developing Sjögren's than women with two X chromosomes (46,XX). Abnormal X chromosome inactivation is also involved in Sjögren's pathogenesis. Sjögren's patients have elevated expression levels of the long non-coding RNA, X-inactive specific transcript (XIST), and its positive transcriptional regulators and methylation defects resulting in aberrant X chromosome inactivation have also been implicated. Speakers in this session will unveil their recent findings in identifying the sex-linked genes and subsequent biological processes that mediate this dose effect and the epigenetic processes that affect X chromosome inactivation, influencing Sjögren's pathogenesis. Further, the implications of this sexual dimorphism in pathogenic triggers of Sjögren's such as SARS-CoV2 infection will be explored. Understanding Sjögren's etiology with respect to sex dependence is integral to developing therapeutics for a disease largely devoid of curative options.

Learning Objectives
  • Learn about the known mechanisms underlying sex bias in Sjögren's
  • Learn about the effect of sexual dimorphism on risk factors of autoimmune triggers such as pathogenic infection
  • Integrate recent findings to create a more holistic view of the sex-dependent factors mediating Sjögren's pathogenesis
Presentation Date
Friday, March 17, 2023

Presenters
  • Valerie Lewis - X Chromosome and the Sex Bias of Sjögren's Disease
  • Yun Liang - Skewing in X-linked gene expression as a molecular explanation for sexual dimorphism in Sjögren's syndrome
  • Brij Singh - Do epigenetic changes lead to Sjögren's Syndrome?
  • Cuong Nguyen - Evidence of SARS-CoV-2 induces Sjögren's syndrome differently in males and females
Sponsoring Groups/Networks
Salivary Research

CE Credits
1.5 Hours

Financial Interest Disclosure:
None

Not eligible for individual purchase must purchase as part of a meeting bundle.